CATALAYER NEWS
Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug - Fierce Biotech
Source: Fierce Biotech · 2026-03-03
Full article text is available in the Catalayer news terminal.
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets